L-asparaginase is a powerful tool in treating acute lymphoblastic leukemia but oncology nurses must be on the look-out for immune hypersensitivity reactions and other serious toxicities, monitoring patients and managing these reactions when they occur.
Health-related quality of life in bladder cancer does not appear impaired with transurethral resection but may be worse with radical treatment.
Study findings underscore the need for more aggressive smoking cessation.
Authors say that screening based on individual life expectancy, rather than age, may improve screening selection and value.
Partial and radical nephrectomy for T3a RCC have similar 5-year rates of overall and cancer-specific survival, according to a propensity score-matched analysis.
Daily or every-other-day external beam PBI regimen preferred over twice-daily regimen due to late toxicity concerns.
Researchers sought to determine the safety and efficacy of emapalumab as treatment and prophylaxis of graft failure in post-HSCT patients.
A secondary analysis of supportive care trial data demonstrated that an approach-oriented coping strategy improved QOL and psychological distress in patients with hematologic cancer undergoing HCT.
Researchers sought to determine which geriatric assessment tools were optimal for predicting chemotherapy toxicity events in older patients with advanced lymphoma.
Researchers investigated the efficacy of several frontline treatment strategies in older patients with DLBCL.
